Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...
Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health ...
A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome ...
Among patients receiving metformin, Lac-Phe levels rose and remained elevated even after hormone therapy began. However, the ...
In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...
Skeletal-related event impact on prostate cancer mortality in the older population in the US: A 24-year trend regression analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent cancer and the fifth leading cause of cancer death among men in 2022. Hormone ...
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results